http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Wed, 25 Feb 2026 08:30:00 -0500 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Press+Releases/Baird+Medical+Accelerates+U.S.+Expansion+in+Interventional+Thyroidology/26055807.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ny.nyc" idsrc="xmltag.org" >NEW YORK</location></span>, <span class="legendSpanClass"><chron>Feb. 25, 2026</chron></span> /PRNewswire/ -- <span value="NASDAQ-NMS:BDMD" idsrc="xmltag.org" >Baird Medical Investment Holdings Ltd.</span> (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a market leader in minimally invasive Microwave Ablation (MWA) technology, today announced new clinical progress across <location value="LC/us" idsrc="xmltag.org" >the United States</location>. This momentum directly supports the Company's strategy to accelerate global growth and expand patient access to advanced, minimally invasive therapies.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/Press+Releases/Baird+Medical+Accelerates+U.S.+Expansion+in+Interventional+Thyroidology/26055807.html Wed, 25 Feb 2026 08:30:00 -0500 A.07309385 A.14196687 A.39855798 A.41370723 A.60001743 BDMD O.03613636 O.19995448 O.20043539 O.21623884 O.22007091 O.68944840 http://www.streetinsider.com/Press+Releases/Baird+Medical+Accelerates+U.S.+Expansion+in+Interventional+Thyroidology/26055807.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ny.nyc" idsrc="xmltag.org" >NEW YORK</location></span>, <span class="legendSpanClass"><chron>Feb. 25, 2026</chron></span> /PRNewswire/ -- <span value="NASDAQ-NMS:BDMD" idsrc="xmltag.org" >Baird Medical Investment Holdings Ltd.</span> (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a market leader in minimally invasive Microwave Ablation (MWA) technology, today announced new clinical progress across <location value="LC/us" idsrc="xmltag.org" >the United States</location>. This momentum directly supports the Company's strategy to accelerate global growth and expand patient access to advanced, minimally invasive therapies.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/Press+Releases/Baird+Medical+Accelerates+U.S.+Expansion+in+Interventional+Thyroidology/26055807.html Wed, 25 Feb 2026 08:30:00 -0500 A.07309385 A.14196687 A.39855798 A.41370723 A.60001743 BDMD O.03613636 O.19995448 O.20043539 O.21623884 O.22007091 O.68944840 http://www.streetinsider.com/Press+Releases/Baird+Medical+Accelerates+U.S.+Expansion+in+Interventional+Thyroidology/26055807.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ny.nyc" idsrc="xmltag.org" >NEW YORK</location></span>, <span class="legendSpanClass"><chron>Feb. 25, 2026</chron></span> /PRNewswire/ -- <span value="NASDAQ-NMS:BDMD" idsrc="xmltag.org" >Baird Medical Investment Holdings Ltd.</span> (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a market leader in minimally invasive Microwave Ablation (MWA) technology, today announced new clinical progress across <location value="LC/us" idsrc="xmltag.org" >the United States</location>. This momentum directly supports the Company's strategy to accelerate global growth and expand patient access to advanced, minimally invasive therapies.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/Press+Releases/Baird+Medical+Accelerates+U.S.+Expansion+in+Interventional+Thyroidology/26055807.html Wed, 25 Feb 2026 08:30:00 -0500 A.07309385 A.14196687 A.39855798 A.41370723 A.60001743 BDMD O.03613636 O.19995448 O.20043539 O.21623884 O.22007091 O.68944840 http://www.streetinsider.com/Press+Releases/Baird+Medical+Accelerates+U.S.+Expansion+in+Interventional+Thyroidology/26055807.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ny.nyc" idsrc="xmltag.org" >NEW YORK</location></span>, <span class="legendSpanClass"><chron>Feb. 25, 2026</chron></span> /PRNewswire/ -- <span value="NASDAQ-NMS:BDMD" idsrc="xmltag.org" >Baird Medical Investment Holdings Ltd.</span> (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a market leader in minimally invasive Microwave Ablation (MWA) technology, today announced new clinical progress across <location value="LC/us" idsrc="xmltag.org" >the United States</location>. This momentum directly supports the Company's strategy to accelerate global growth and expand patient access to advanced, minimally invasive therapies.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/Press+Releases/Baird+Medical+Accelerates+U.S.+Expansion+in+Interventional+Thyroidology/26055807.html Wed, 25 Feb 2026 08:30:00 -0500 A.07309385 A.14196687 A.39855798 A.41370723 A.60001743 BDMD O.03613636 O.19995448 O.20043539 O.21623884 O.22007091 O.68944840 http://www.streetinsider.com/Press+Releases/Baird+Medical+Accelerates+U.S.+Expansion+in+Interventional+Thyroidology/26055807.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ny.nyc" idsrc="xmltag.org" >NEW YORK</location></span>, <span class="legendSpanClass"><chron>Feb. 25, 2026</chron></span> /PRNewswire/ -- <span value="NASDAQ-NMS:BDMD" idsrc="xmltag.org" >Baird Medical Investment Holdings Ltd.</span> (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a market leader in minimally invasive Microwave Ablation (MWA) technology, today announced new clinical progress across <location value="LC/us" idsrc="xmltag.org" >the United States</location>. This momentum directly supports the Company's strategy to accelerate global growth and expand patient access to advanced, minimally invasive therapies.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/Press+Releases/Baird+Medical+Accelerates+U.S.+Expansion+in+Interventional+Thyroidology/26055807.html Wed, 25 Feb 2026 08:30:00 -0500 A.07309385 A.14196687 A.39855798 A.41370723 A.60001743 BDMD O.03613636 O.19995448 O.20043539 O.21623884 O.22007091 O.68944840 http://www.streetinsider.com/Press+Releases/Baird+Medical+Accelerates+U.S.+Expansion+in+Interventional+Thyroidology/26055807.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ny.nyc" idsrc="xmltag.org" >NEW YORK</location></span>, <span class="legendSpanClass"><chron>Feb. 25, 2026</chron></span> /PRNewswire/ -- <span value="NASDAQ-NMS:BDMD" idsrc="xmltag.org" >Baird Medical Investment Holdings Ltd.</span> (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a market leader in minimally invasive Microwave Ablation (MWA) technology, today announced new clinical progress across <location value="LC/us" idsrc="xmltag.org" >the United States</location>. This momentum directly supports the Company's strategy to accelerate global growth and expand patient access to advanced, minimally invasive therapies.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/Press+Releases/Baird+Medical+Accelerates+U.S.+Expansion+in+Interventional+Thyroidology/26055807.html Wed, 25 Feb 2026 08:30:00 -0500 A.07309385 A.14196687 A.39855798 A.41370723 A.60001743 BDMD O.03613636 O.19995448 O.20043539 O.21623884 O.22007091 O.68944840 http://www.streetinsider.com/Press+Releases/Baird+Medical+Accelerates+U.S.+Expansion+in+Interventional+Thyroidology/26055807.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ny.nyc" idsrc="xmltag.org" >NEW YORK</location></span>, <span class="legendSpanClass"><chron>Feb. 25, 2026</chron></span> /PRNewswire/ -- <span value="NASDAQ-NMS:BDMD" idsrc="xmltag.org" >Baird Medical Investment Holdings Ltd.</span> (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a market leader in minimally invasive Microwave Ablation (MWA) technology, today announced new clinical progress across <location value="LC/us" idsrc="xmltag.org" >the United States</location>. This momentum directly supports the Company's strategy to accelerate global growth and expand patient access to advanced, minimally invasive therapies.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/Press+Releases/Baird+Medical+Accelerates+U.S.+Expansion+in+Interventional+Thyroidology/26055807.html Wed, 25 Feb 2026 08:30:00 -0500 A.07309385 A.14196687 A.39855798 A.41370723 A.60001743 BDMD O.03613636 O.19995448 O.20043539 O.21623884 O.22007091 O.68944840 http://www.streetinsider.com/Press+Releases/Baird+Medical+Accelerates+U.S.+Expansion+in+Interventional+Thyroidology/26055807.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ny.nyc" idsrc="xmltag.org" >NEW YORK</location></span>, <span class="legendSpanClass"><chron>Feb. 25, 2026</chron></span> /PRNewswire/ -- <span value="NASDAQ-NMS:BDMD" idsrc="xmltag.org" >Baird Medical Investment Holdings Ltd.</span> (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a market leader in minimally invasive Microwave Ablation (MWA) technology, today announced new clinical progress across <location value="LC/us" idsrc="xmltag.org" >the United States</location>. This momentum directly supports the Company's strategy to accelerate global growth and expand patient access to advanced, minimally invasive therapies.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/Press+Releases/Baird+Medical+Accelerates+U.S.+Expansion+in+Interventional+Thyroidology/26055807.html Wed, 25 Feb 2026 08:30:00 -0500 A.07309385 A.14196687 A.39855798 A.41370723 A.60001743 BDMD O.03613636 O.19995448 O.20043539 O.21623884 O.22007091 O.68944840 http://www.streetinsider.com/Press+Releases/Baird+Medical+Accelerates+U.S.+Expansion+in+Interventional+Thyroidology/26055807.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ny.nyc" idsrc="xmltag.org" >NEW YORK</location></span>, <span class="legendSpanClass"><chron>Feb. 25, 2026</chron></span> /PRNewswire/ -- <span value="NASDAQ-NMS:BDMD" idsrc="xmltag.org" >Baird Medical Investment Holdings Ltd.</span> (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a market leader in minimally invasive Microwave Ablation (MWA) technology, today announced new clinical progress across <location value="LC/us" idsrc="xmltag.org" >the United States</location>. This momentum directly supports the Company's strategy to accelerate global growth and expand patient access to advanced, minimally invasive therapies.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/Press+Releases/Baird+Medical+Accelerates+U.S.+Expansion+in+Interventional+Thyroidology/26055807.html Wed, 25 Feb 2026 08:30:00 -0500 A.07309385 A.14196687 A.39855798 A.41370723 A.60001743 BDMD O.03613636 O.19995448 O.20043539 O.21623884 O.22007091 O.68944840 http://www.streetinsider.com/Press+Releases/Baird+Medical+Accelerates+U.S.+Expansion+in+Interventional+Thyroidology/26055807.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ny.nyc" idsrc="xmltag.org" >NEW YORK</location></span>, <span class="legendSpanClass"><chron>Feb. 25, 2026</chron></span> /PRNewswire/ -- <span value="NASDAQ-NMS:BDMD" idsrc="xmltag.org" >Baird Medical Investment Holdings Ltd.</span> (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a market leader in minimally invasive Microwave Ablation (MWA) technology, today announced new clinical progress across <location value="LC/us" idsrc="xmltag.org" >the United States</location>. This momentum directly supports the Company's strategy to accelerate global growth and expand patient access to advanced, minimally invasive therapies.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/Press+Releases/Baird+Medical+Accelerates+U.S.+Expansion+in+Interventional+Thyroidology/26055807.html Wed, 25 Feb 2026 08:30:00 -0500 A.07309385 A.14196687 A.39855798 A.41370723 A.60001743 BDMD O.03613636 O.19995448 O.20043539 O.21623884 O.22007091 O.68944840 http://www.streetinsider.com/Press+Releases/Baird+Medical+Accelerates+U.S.+Expansion+in+Interventional+Thyroidology/26055807.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ny.nyc" idsrc="xmltag.org" >NEW YORK</location></span>, <span class="legendSpanClass"><chron>Feb. 25, 2026</chron></span> /PRNewswire/ -- <span value="NASDAQ-NMS:BDMD" idsrc="xmltag.org" >Baird Medical Investment Holdings Ltd.</span> (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a market leader in minimally invasive Microwave Ablation (MWA) technology, today announced new clinical progress across <location value="LC/us" idsrc="xmltag.org" >the United States</location>. This momentum directly supports the Company's strategy to accelerate global growth and expand patient access to advanced, minimally invasive therapies.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/Press+Releases/Baird+Medical+Accelerates+U.S.+Expansion+in+Interventional+Thyroidology/26055807.html Wed, 25 Feb 2026 08:30:00 -0500 A.07309385 A.14196687 A.39855798 A.41370723 A.60001743 BDMD O.03613636 O.19995448 O.20043539 O.21623884 O.22007091 O.68944840 http://www.streetinsider.com/Press+Releases/Baird+Medical+Accelerates+U.S.+Expansion+in+Interventional+Thyroidology/26055807.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ny.nyc" idsrc="xmltag.org" >NEW YORK</location></span>, <span class="legendSpanClass"><chron>Feb. 25, 2026</chron></span> /PRNewswire/ -- <span value="NASDAQ-NMS:BDMD" idsrc="xmltag.org" >Baird Medical Investment Holdings Ltd.</span> (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a market leader in minimally invasive Microwave Ablation (MWA) technology, today announced new clinical progress across <location value="LC/us" idsrc="xmltag.org" >the United States</location>. This momentum directly supports the Company's strategy to accelerate global growth and expand patient access to advanced, minimally invasive therapies.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/Press+Releases/Baird+Medical+Accelerates+U.S.+Expansion+in+Interventional+Thyroidology/26055807.html Wed, 25 Feb 2026 08:30:00 -0500 A.07309385 A.14196687 A.39855798 A.41370723 A.60001743 BDMD O.03613636 O.19995448 O.20043539 O.21623884 O.22007091 O.68944840 http://www.streetinsider.com/PRNewswire/Baird+Medical+Accelerates+U.S.+Expansion+in+Interventional+Thyroidology/26055807.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ny.nyc" idsrc="xmltag.org" >NEW YORK</location></span>, <span class="legendSpanClass"><chron>Feb. 25, 2026</chron></span> /PRNewswire/ -- <span value="NASDAQ-NMS:BDMD" idsrc="xmltag.org" >Baird Medical Investment Holdings Ltd.</span> (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a market leader in minimally invasive Microwave Ablation (MWA) technology, today announced new clinical progress across <location value="LC/us" idsrc="xmltag.org" >the United States</location>. This momentum directly supports the Company's strategy to accelerate global growth and expand patient access to advanced, minimally invasive therapies.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/PRNewswire/Baird+Medical+Accelerates+U.S.+Expansion+in+Interventional+Thyroidology/26055807.html Wed, 25 Feb 2026 08:30:00 -0500 A.07309385 A.14196687 A.39855798 A.41370723 A.60001743 BDMD O.03613636 O.19995448 O.20043539 O.21623884 O.22007091 O.68944840 http://www.streetinsider.com/PRNewswire/Baird+Medical+Accelerates+U.S.+Expansion+in+Interventional+Thyroidology/26055807.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ny.nyc" idsrc="xmltag.org" >NEW YORK</location></span>, <span class="legendSpanClass"><chron>Feb. 25, 2026</chron></span> /PRNewswire/ -- <span value="NASDAQ-NMS:BDMD" idsrc="xmltag.org" >Baird Medical Investment Holdings Ltd.</span> (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a market leader in minimally invasive Microwave Ablation (MWA) technology, today announced new clinical progress across <location value="LC/us" idsrc="xmltag.org" >the United States</location>. This momentum directly supports the Company's strategy to accelerate global growth and expand patient access to advanced, minimally invasive therapies.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/PRNewswire/Baird+Medical+Accelerates+U.S.+Expansion+in+Interventional+Thyroidology/26055807.html Wed, 25 Feb 2026 08:30:00 -0500 A.07309385 A.14196687 A.39855798 A.41370723 A.60001743 BDMD O.03613636 O.19995448 O.20043539 O.21623884 O.22007091 O.68944840 http://www.streetinsider.com/PRNewswire/Baird+Medical+Accelerates+U.S.+Expansion+in+Interventional+Thyroidology/26055807.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ny.nyc" idsrc="xmltag.org" >NEW YORK</location></span>, <span class="legendSpanClass"><chron>Feb. 25, 2026</chron></span> /PRNewswire/ -- <span value="NASDAQ-NMS:BDMD" idsrc="xmltag.org" >Baird Medical Investment Holdings Ltd.</span> (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a market leader in minimally invasive Microwave Ablation (MWA) technology, today announced new clinical progress across <location value="LC/us" idsrc="xmltag.org" >the United States</location>. This momentum directly supports the Company's strategy to accelerate global growth and expand patient access to advanced, minimally invasive therapies.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/PRNewswire/Baird+Medical+Accelerates+U.S.+Expansion+in+Interventional+Thyroidology/26055807.html Wed, 25 Feb 2026 08:30:00 -0500 A.07309385 A.14196687 A.39855798 A.41370723 A.60001743 BDMD O.03613636 O.19995448 O.20043539 O.21623884 O.22007091 O.68944840 http://www.streetinsider.com/PRNewswire/Baird+Medical+Accelerates+U.S.+Expansion+in+Interventional+Thyroidology/26055807.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ny.nyc" idsrc="xmltag.org" >NEW YORK</location></span>, <span class="legendSpanClass"><chron>Feb. 25, 2026</chron></span> /PRNewswire/ -- <span value="NASDAQ-NMS:BDMD" idsrc="xmltag.org" >Baird Medical Investment Holdings Ltd.</span> (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a market leader in minimally invasive Microwave Ablation (MWA) technology, today announced new clinical progress across <location value="LC/us" idsrc="xmltag.org" >the United States</location>. This momentum directly supports the Company's strategy to accelerate global growth and expand patient access to advanced, minimally invasive therapies.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/PRNewswire/Baird+Medical+Accelerates+U.S.+Expansion+in+Interventional+Thyroidology/26055807.html Wed, 25 Feb 2026 08:30:00 -0500 A.07309385 A.14196687 A.39855798 A.41370723 A.60001743 BDMD O.03613636 O.19995448 O.20043539 O.21623884 O.22007091 O.68944840 http://www.streetinsider.com/PRNewswire/Baird+Medical+Accelerates+U.S.+Expansion+in+Interventional+Thyroidology/26055807.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ny.nyc" idsrc="xmltag.org" >NEW YORK</location></span>, <span class="legendSpanClass"><chron>Feb. 25, 2026</chron></span> /PRNewswire/ -- <span value="NASDAQ-NMS:BDMD" idsrc="xmltag.org" >Baird Medical Investment Holdings Ltd.</span> (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a market leader in minimally invasive Microwave Ablation (MWA) technology, today announced new clinical progress across <location value="LC/us" idsrc="xmltag.org" >the United States</location>. This momentum directly supports the Company's strategy to accelerate global growth and expand patient access to advanced, minimally invasive therapies.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/PRNewswire/Baird+Medical+Accelerates+U.S.+Expansion+in+Interventional+Thyroidology/26055807.html Wed, 25 Feb 2026 08:30:00 -0500 A.07309385 A.14196687 A.39855798 A.41370723 A.60001743 BDMD O.03613636 O.19995448 O.20043539 O.21623884 O.22007091 O.68944840 http://www.streetinsider.com/PRNewswire/Baird+Medical+Accelerates+U.S.+Expansion+in+Interventional+Thyroidology/26055807.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ny.nyc" idsrc="xmltag.org" >NEW YORK</location></span>, <span class="legendSpanClass"><chron>Feb. 25, 2026</chron></span> /PRNewswire/ -- <span value="NASDAQ-NMS:BDMD" idsrc="xmltag.org" >Baird Medical Investment Holdings Ltd.</span> (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a market leader in minimally invasive Microwave Ablation (MWA) technology, today announced new clinical progress across <location value="LC/us" idsrc="xmltag.org" >the United States</location>. This momentum directly supports the Company's strategy to accelerate global growth and expand patient access to advanced, minimally invasive therapies.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/PRNewswire/Baird+Medical+Accelerates+U.S.+Expansion+in+Interventional+Thyroidology/26055807.html Wed, 25 Feb 2026 08:30:00 -0500 A.07309385 A.14196687 A.39855798 A.41370723 A.60001743 BDMD O.03613636 O.19995448 O.20043539 O.21623884 O.22007091 O.68944840 http://www.streetinsider.com/PRNewswire/Baird+Medical+Accelerates+U.S.+Expansion+in+Interventional+Thyroidology/26055807.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ny.nyc" idsrc="xmltag.org" >NEW YORK</location></span>, <span class="legendSpanClass"><chron>Feb. 25, 2026</chron></span> /PRNewswire/ -- <span value="NASDAQ-NMS:BDMD" idsrc="xmltag.org" >Baird Medical Investment Holdings Ltd.</span> (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a market leader in minimally invasive Microwave Ablation (MWA) technology, today announced new clinical progress across <location value="LC/us" idsrc="xmltag.org" >the United States</location>. This momentum directly supports the Company's strategy to accelerate global growth and expand patient access to advanced, minimally invasive therapies.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/PRNewswire/Baird+Medical+Accelerates+U.S.+Expansion+in+Interventional+Thyroidology/26055807.html Wed, 25 Feb 2026 08:30:00 -0500 A.07309385 A.14196687 A.39855798 A.41370723 A.60001743 BDMD O.03613636 O.19995448 O.20043539 O.21623884 O.22007091 O.68944840 http://www.streetinsider.com/PRNewswire/Baird+Medical+Accelerates+U.S.+Expansion+in+Interventional+Thyroidology/26055807.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ny.nyc" idsrc="xmltag.org" >NEW YORK</location></span>, <span class="legendSpanClass"><chron>Feb. 25, 2026</chron></span> /PRNewswire/ -- <span value="NASDAQ-NMS:BDMD" idsrc="xmltag.org" >Baird Medical Investment Holdings Ltd.</span> (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a market leader in minimally invasive Microwave Ablation (MWA) technology, today announced new clinical progress across <location value="LC/us" idsrc="xmltag.org" >the United States</location>. This momentum directly supports the Company's strategy to accelerate global growth and expand patient access to advanced, minimally invasive therapies.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/PRNewswire/Baird+Medical+Accelerates+U.S.+Expansion+in+Interventional+Thyroidology/26055807.html Wed, 25 Feb 2026 08:30:00 -0500 A.07309385 A.14196687 A.39855798 A.41370723 A.60001743 BDMD O.03613636 O.19995448 O.20043539 O.21623884 O.22007091 O.68944840 http://www.streetinsider.com/PRNewswire/Baird+Medical+Accelerates+U.S.+Expansion+in+Interventional+Thyroidology/26055807.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ny.nyc" idsrc="xmltag.org" >NEW YORK</location></span>, <span class="legendSpanClass"><chron>Feb. 25, 2026</chron></span> /PRNewswire/ -- <span value="NASDAQ-NMS:BDMD" idsrc="xmltag.org" >Baird Medical Investment Holdings Ltd.</span> (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a market leader in minimally invasive Microwave Ablation (MWA) technology, today announced new clinical progress across <location value="LC/us" idsrc="xmltag.org" >the United States</location>. This momentum directly supports the Company's strategy to accelerate global growth and expand patient access to advanced, minimally invasive therapies.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/PRNewswire/Baird+Medical+Accelerates+U.S.+Expansion+in+Interventional+Thyroidology/26055807.html Wed, 25 Feb 2026 08:30:00 -0500 A.07309385 A.14196687 A.39855798 A.41370723 A.60001743 BDMD O.03613636 O.19995448 O.20043539 O.21623884 O.22007091 O.68944840 http://www.streetinsider.com/PRNewswire/Baird+Medical+Accelerates+U.S.+Expansion+in+Interventional+Thyroidology/26055807.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ny.nyc" idsrc="xmltag.org" >NEW YORK</location></span>, <span class="legendSpanClass"><chron>Feb. 25, 2026</chron></span> /PRNewswire/ -- <span value="NASDAQ-NMS:BDMD" idsrc="xmltag.org" >Baird Medical Investment Holdings Ltd.</span> (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a market leader in minimally invasive Microwave Ablation (MWA) technology, today announced new clinical progress across <location value="LC/us" idsrc="xmltag.org" >the United States</location>. This momentum directly supports the Company's strategy to accelerate global growth and expand patient access to advanced, minimally invasive therapies.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/PRNewswire/Baird+Medical+Accelerates+U.S.+Expansion+in+Interventional+Thyroidology/26055807.html Wed, 25 Feb 2026 08:30:00 -0500 A.07309385 A.14196687 A.39855798 A.41370723 A.60001743 BDMD O.03613636 O.19995448 O.20043539 O.21623884 O.22007091 O.68944840 http://www.streetinsider.com/PRNewswire/Baird+Medical+Accelerates+U.S.+Expansion+in+Interventional+Thyroidology/26055807.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ny.nyc" idsrc="xmltag.org" >NEW YORK</location></span>, <span class="legendSpanClass"><chron>Feb. 25, 2026</chron></span> /PRNewswire/ -- <span value="NASDAQ-NMS:BDMD" idsrc="xmltag.org" >Baird Medical Investment Holdings Ltd.</span> (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a market leader in minimally invasive Microwave Ablation (MWA) technology, today announced new clinical progress across <location value="LC/us" idsrc="xmltag.org" >the United States</location>. This momentum directly supports the Company's strategy to accelerate global growth and expand patient access to advanced, minimally invasive therapies.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/PRNewswire/Baird+Medical+Accelerates+U.S.+Expansion+in+Interventional+Thyroidology/26055807.html Wed, 25 Feb 2026 08:30:00 -0500 A.07309385 A.14196687 A.39855798 A.41370723 A.60001743 BDMD O.03613636 O.19995448 O.20043539 O.21623884 O.22007091 O.68944840 http://www.streetinsider.com/PRNewswire/Baird+Medical+Accelerates+U.S.+Expansion+in+Interventional+Thyroidology/26055807.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ny.nyc" idsrc="xmltag.org" >NEW YORK</location></span>, <span class="legendSpanClass"><chron>Feb. 25, 2026</chron></span> /PRNewswire/ -- <span value="NASDAQ-NMS:BDMD" idsrc="xmltag.org" >Baird Medical Investment Holdings Ltd.</span> (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a market leader in minimally invasive Microwave Ablation (MWA) technology, today announced new clinical progress across <location value="LC/us" idsrc="xmltag.org" >the United States</location>. This momentum directly supports the Company's strategy to accelerate global growth and expand patient access to advanced, minimally invasive therapies.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/PRNewswire/Baird+Medical+Accelerates+U.S.+Expansion+in+Interventional+Thyroidology/26055807.html Wed, 25 Feb 2026 08:30:00 -0500 A.07309385 A.14196687 A.39855798 A.41370723 A.60001743 BDMD O.03613636 O.19995448 O.20043539 O.21623884 O.22007091 O.68944840 http://www.streetinsider.com/Press+Releases/Baird+Medical+to+Showcase+Minimally+Invasive+Thyroid+Solutions+at+Upcoming+US+Clinical+Conferences/26026601.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ny.nyc" idsrc="xmltag.org" >NEW YORK</location></span>, <span class="legendSpanClass"><chron>Feb. 19, 2026</chron></span> /PRNewswire/ -- <span value="NASDAQ-NMS:BDMD" idsrc="xmltag.org" >Baird Medical Investment Holdings Ltd.</span> (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a market leader in minimally invasive Microwave Ablation (MWA) technology, today announced its participation for three major clinical conferences this quarter. These events are pivotal to the company's expansion, providing <location value="LC/us" idsrc="xmltag.org" >U.S.</location> clinicians direct access to its innovative needle-based therapies for thyroid conditions.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/Press+Releases/Baird+Medical+to+Showcase+Minimally+Invasive+Thyroid+Solutions+at+Upcoming+US+Clinical+Conferences/26026601.html Thu, 19 Feb 2026 08:30:00 -0500 A.07309385 A.14196687 A.39855798 A.60001743 BDMD O.03613636 O.19995448 O.20043539 O.21623884 O.68944840